SG Americas Securities’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

SG Americas Securities’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,015	Closed	-$123K	–	3657
2022 Q4	$123K	Buy	+10,015	New	+$239K	﹤0.01%	2577

SG Americas Securities's CINC Position: Q1 2023 in Review

SG Americas Securities sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 10,015 shares — an estimated $123K sold.

SG Americas Securities first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $123K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

SG Americas Securities reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
SG Americas Securities sold 10,015 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $123K.
SG Americas Securities first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
SG Americas Securities's CinCor Pharma, Inc. Common Stock position peaked at $123K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on SG Americas Securities's 13F filing for Q1 2023, filed 28 Apr 2023.